دورية أكاديمية

LBA41 Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation

التفاصيل البيبلوغرافية
العنوان: LBA41 Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation
المؤلفون: Ascierto, P.A., Mandala, M., Ferrucci, P.F., Guidoboni, M., Rutkowski, P., Ferraresi, V., Fernandez, A.M. Arance, Guida, M., Maiello, E., Gogas, H.J., Richtig, E., Fierro, M.T., Lebbe, C., Helgadottir, H., Melero, I., Palmieri, G., Giannarelli, D., Grimaldi, A.M., Dummer, R., Sileni, V. Chiarion
المصدر: In Annals of Oncology September 2022 33 Supplement 7:S1408-S1409
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2022.08.040